Efficacy Study of Patient Preoperative Preps In-vivo
Completed · Phase 3
Conditions studied: Surgical Skin Preparation
In brief
The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.
Key facts
- Study ID
- NCT04756154
- Run by
- Solventum US LLC
- People needed
- 154
- Starts
- 2020-07-06
- Expected to finish
- 2021-04-28
- Last updated by the study team
- 2024-10-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects of any race
- Subjects in good health
- Minimum skin flora baseline requirements on inguinal region
You may not qualify if…
- Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test area
- Topical antimicrobial exposure within 14 days prior to screening and treatment days
- Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days
Where it is running
- Microbac Laboratories, Inc — Sterling, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.